Amber Salzman

Chief Executive Officer, Epicrispr Biotechnologies

Member since April 2026

—

Volume

—

Sold

—

Financed

Closed

25K sf

Area

About

Amber Salzman, Ph.D., is Epicrispr’s chief executive officer and director. Dr. Salzman is a leader with more than 30 years of experience in the pharmaceuticals industry. Before joining Epicrispr, Dr. Salzman served as the president and CEO of Ohana Biosciences, pioneering the industry’s first sperm biology platform. Before Ohana, she served as the ...

Member since April 2026

Deals

LEASED

Amber Salzman Of CBRE Represents Epicrispr Biotechnologies In 24,780 Square Foot Lease Renewal In South San Francisco

7000 Shoreline Court, South San Francisco, CA

CACRE

Apr 23, 2026